ST Leadership, Ethics & Drug Development

Special Topics in Leadership, Ethics and Drug Development

In Ethical leadership decisions regarding drug development, regulation and delivery is a multi-dimensional process with varied stakeholders, each having their own objectives.  This course will provide students with a look at how leaders in health care faced with real-life decisions utilized ethics to determine an outcome. The course is designed as a one week intensive in-person course, with two guest lecturers per day from industry, government, funding organizations, HCPs and patient organizations to help students gain a greater understanding of all stakeholders involved in health care decision making. 

Through posted and classroom discussion, speakers will address and students will be challenged to consider the following questions:

• Who are the relevant stakeholders?  What are their preferences and do they conflict?  If so, how is this conflict best resolved?
• How do we apply a bioethical framework – the principles of beneficence, nonmaleficence, autonomy and justice -- to this problem?
• When understanding how a new medicine is developed, how are the long and short term risks, large and small, weighed and evaluated against potential benefits?
• Does industry consider justice– such as access and affordability – when deciding what products to develop?
• What would you advise if you were an ethics consultant?
• What do you think about the actions taken to address the issue?
• How are ethical questions handled within organizations?  Are consultants used formally or informally to ensure outside perspectives?

This course is for anyone with an interest in learning from leaders in the field and exploring real-life cases of bioethical decisions that impact all of us.